Company intelligence / Profile preview
JGL Group
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Commercial
Overview
JGL produces over 300 products daily in their Pharma Valley facility, with a focus on sterile ophthalmology and ENT products. They have a strong presence in 60 markets worldwide with 86% of revenue coming from exports[7].
- Therapeutic areas
- ImmunologyOtherDermatologyGastroenterologyOphthalmologyInfectious Diseases
- Modalities
- Sterile solutionssuspensionsemulsionsspraysdropsaerosols
- Industry
- Biotech
Drug pipeline
7 assets6 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on JGL Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JGL Group.